Lupus Nephritis

Lupus nephritis is the kidney involvement of systemic lupus erythematosus, an immune-complex glomerulonephritis that ranges from minimal mesangial changes to diffuse proliferative and membranous patterns. It is one of the most consequential organ manifestations of lupus and a paradigm of immune-complex-mediated glomerular injury, classified histologically into six classes that orient prognosis and study.

Definition

Lupus nephritis is glomerular disease caused by deposition of immune complexes in the kidney in systemic lupus erythematosus, classified by the International Society of Nephrology/Renal Pathology Society into classes I-VI according to the pattern and distribution of glomerular injury.

Scope

This entry covers the immune-complex pathogenesis of lupus nephritis, the ISN/RPS histologic classification, the spectrum of clinical presentation from proteinuria to nephritic and rapidly progressive disease, and the controlled-trial evidence base. It is a reference description of mechanism, classification, and high-level evidence; it does not provide diagnostic criteria, dosing, or individualised treatment, which rest with current guidelines and treating clinicians.

Core questions

• How do autoantibodies and immune complexes in lupus produce glomerular injury?
• What do the ISN/RPS classes describe, and why does class matter for prognosis and study?
• How does the clinical presentation range from isolated proteinuria to rapidly progressive nephritis?
• What controlled-trial evidence informs the modern framework for induction and maintenance?

Key concepts

• Immune-complex deposition
• Anti-double-stranded-DNA and other autoantibodies
• ISN/RPS classification (classes I-VI)
• Proliferative (class III/IV) lesions
• Membranous lupus nephritis (class V)
• Complement activation and hypocomplementaemia
• Activity and chronicity indices

Mechanisms

In systemic lupus erythematosus, loss of tolerance to nuclear antigens generates autoantibodies (including anti-double-stranded DNA) and immune complexes that deposit in the glomerulus or form in situ, activating complement and recruiting inflammatory cells. The location and extent of deposition determine the histologic pattern: mesangial deposits produce mild (class I-II) disease, subendothelial deposits drive proliferative (class III focal, class IV diffuse) nephritis with a nephritic and potentially crescentic picture, and subepithelial deposits produce membranous (class V) disease with a nephrotic pattern; mixed patterns occur. Activity and chronicity of the lesion are scored to describe potentially reversible inflammation versus established scarring (Weening 2004; Rovin 2021).

Clinical relevance

The ISN/RPS classification is a reference framework that links the histologic pattern of lupus nephritis to its clinical behaviour and prognosis and structures the controlled-trial literature. This entry summarises mechanism, classification, and high-level evidence for reference and education; it does not provide diagnostic thresholds, dosing, or individualised treatment, which are governed by current guidelines and treating clinicians.

Epidemiology

Kidney involvement develops in a substantial proportion of people with systemic lupus erythematosus and is more frequent and often more severe in certain ancestral groups and in those with earlier-onset disease. Lupus nephritis is an important contributor to morbidity in lupus and, in some patients, to chronic kidney disease (Weening 2004; Rovin 2021).

History

Renal involvement was recognised early as a major determinant of outcome in systemic lupus erythematosus. The World Health Organization classification of the 1970s-1980s was revised by the International Society of Nephrology and Renal Pathology Society in 2004 into the six-class scheme used today, and a succession of randomised trials — comparing induction regimens and testing combination and maintenance strategies — built the modern evidence base (Weening 2004; Appel 2009; Zhang 2017).

Debates

How well does histologic class predict outcome and guide categorisation?

The ISN/RPS classes capture important differences in pattern and prognosis, but debate continues over the prognostic weight of activity and chronicity indices and the handling of mixed and transforming lesions, prompting ongoing refinement of the scheme.

Key figures

• Jan J. Weening
• Vivette D. D'Agati
• Gerald B. Appel
• Brad H. Rovin

Seminal works

• weening2004
• appel2009
• rovin2021

Frequently asked questions

What do the ISN/RPS classes of lupus nephritis represent?

They describe the pattern and distribution of glomerular immune-complex injury, from minimal mesangial change (class I-II) through focal and diffuse proliferative disease (class III-IV) to membranous (class V) and advanced sclerosing (class VI) lesions, which differ in clinical behaviour and prognosis.

Why is lupus nephritis considered an immune-complex disease?

Because the glomerular injury is driven by deposition of antigen-antibody complexes with complement activation, producing the granular immunofluorescence pattern that defines immune-complex glomerulonephritis.